Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,180,587
  • Shares Outstanding, K 115,927
  • Annual Sales, $ 353,870 K
  • Annual Income, $ 106,010 K
  • 60-Month Beta 0.75
  • Price/Sales 6.38
  • Price/Cash Flow 20.83
  • Price/Book 4.36
Trade CORT with:

Options Overview Details

View History
  • Implied Volatility 43.05%
  • Historical Volatility 39.89%
  • IV Percentile 21%
  • IV Rank 6.23%
  • IV High 208.16% on 11/12/20
  • IV Low 32.08% on 09/01/21
  • Put/Call Vol Ratio 0.67
  • Today's Volume 55
  • Volume Avg (30-Day) 133
  • Put/Call OI Ratio 2.00
  • Today's Open Interest 2,401
  • Open Int (30-Day) 669

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.19
  • Number of Estimates 3
  • High Estimate 0.21
  • Low Estimate 0.18
  • Prior Year 0.17
  • Growth Rate Est. (year over year) +11.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.76 +0.27%
on 10/21/21
21.58 -12.84%
on 10/12/21
-1.44 (-7.11%)
since 09/21/21
3-Month
18.76 +0.27%
on 10/21/21
21.99 -14.44%
on 08/06/21
-1.94 (-9.35%)
since 07/21/21
52-Week
16.52 +13.86%
on 10/30/20
31.18 -39.67%
on 02/09/21
+1.37 (+7.86%)
since 10/21/20

Most Recent Stories

More News
Why Corcept Therapeutics is a Great Value Stock to Buy

Biotech stocks have certainly gained prominence over the past year and a half as a result of companies looking for treatments for COVID. The biotech industry is expected to continue growing due to the...

CORT : 18.81 (-3.44%)
Is Jazz Pharmaceuticals a Good Growth Stock to Invest In?

Shares of the Ireland-based biopharmaceutical company Jazz Pharmaceuticals (JAZZ) have declined 26.7% over the past three months. While the company’s recent drug approvals and collaborations could boost...

JAZZ : 144.14 (-1.05%)
SBHMY : 17.2050 (+3.71%)
CORT : 18.81 (-3.44%)
Tupperware, Splunk rise; Corcept, NexGen Health fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

SPLK : 168.83 (+0.93%)
TUP : 23.55 (+1.86%)
DDD : 27.98 (-0.57%)
CORT : 18.81 (-3.44%)
SCVL : 33.85 (+2.89%)
SAFM : 187.88 (+0.80%)
L Brands, Sonos rise; United Airlines, Cubic fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially Thursday:

UAL : 46.72 (+1.68%)
SONO : 32.41 (-1.22%)
JACK : 100.23 (-0.51%)
NUAN : 55.13 (+0.07%)
CUB : 75.00 (+0.32%)
CORT : 18.81 (-3.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol....

See More

Key Turning Points

3rd Resistance Point 19.88
2nd Resistance Point 19.64
1st Resistance Point 19.23
Last Price 18.81
1st Support Level 18.58
2nd Support Level 18.34
3rd Support Level 17.93

See More

52-Week High 31.18
Fibonacci 61.8% 25.58
Fibonacci 50% 23.85
Fibonacci 38.2% 22.12
Last Price 18.81
52-Week Low 16.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar